T1	AdverseReaction 39 50	ANAPHYLAXIS
T2	Factor 31 35	RISK
T3	AdverseReaction 52 68	HYPERSENSITIVITY
T4	AdverseReaction 73 98	IMMUNE-MEDIATED REACTIONS
T5	AdverseReaction 112 137	CARDIORESPIRATORY FAILURE
T6	Factor 104 108	RISK
T7	AdverseReaction 161 172	ANAPHYLAXIS
T8	AdverseReaction 174 190	HYPERSENSITIVITY
T9	AdverseReaction 195 220	IMMUNE-MEDIATED REACTIONS
T10	AdverseReaction 234 259	CARDIORESPIRATORY FAILURE
T11	Factor 153 157	RISK
T12	Factor 226 230	RISK
T13	AdverseReaction 286 308	anaphylactic reactions
T14	Severity 269 285	Life-threatening
T15	AdverseReaction 320 346	hypersensitivity reactions
T16	Severity 313 319	severe
T17	AdverseReaction 362 382	respiratory distress
T18	AdverseReaction 384 391	hypoxia
T19	AdverseReaction 393 398	apnea
T20	AdverseReaction 400 407	dyspnea
T21	AdverseReaction 409 420	bradycardia
T22	AdverseReaction 422 433	tachycardia
T23	AdverseReaction 435 447	bronchospasm
T24	AdverseReaction 449 465	throat tightness
T25	AdverseReaction 467 478	hypotension
T26	AdverseReaction 480 490	angioedema
T27	AdverseReaction 502 508;516 524	tongue swelling
T28	AdverseReaction 512 524	lip swelling
T29	AdverseReaction 526 543	periorbital edema
T30	AdverseReaction 549 559	face edema
T31	AdverseReaction 566 575	urticaria
T32	AdverseReaction 656 681	Immune-mediated reactions
T33	AdverseReaction 696 707	proteinuria
T34	AdverseReaction 709 727	nephrotic syndrome
T35	AdverseReaction 733 757	necrotizing skin lesions
T36	AdverseReaction 1408 1422	fluid overload
T37	AdverseReaction 1339 1360;1378 1400	acute exacerbation of respiratory compromise
T38	Factor 1313 1316	may
T39	Severity 1331 1338	serious
T40	AdverseReaction 1339 1360;1367 1374;1390 1400	acute exacerbation of cardiac compromise
T41	AdverseReaction 1528 1539	ANAPHYLAXIS
T42	AdverseReaction 1541 1557	HYPERSENSITIVITY
T43	AdverseReaction 1562 1587	IMMUNE-MEDIATED REACTIONS
T44	AdverseReaction 1601 1626	CARDIORESPIRATORY FAILURE
T45	Factor 1520 1524	RISK
T46	Factor 1593 1597	RISK
T47	AdverseReaction 1720 1742	anaphylactic reactions
T48	Severity 1703 1719	Life-threatening
T49	AdverseReaction 1754 1780	hypersensitivity reactions
T50	Severity 1747 1753	severe
T51	AdverseReaction 1859 1884	Immune-mediated reactions
T52	AdverseReaction 1899 1910	proteinuria
T53	AdverseReaction 1912 1930	nephrotic syndrome
T54	AdverseReaction 1936 1960	necrotizing skin lesions
T55	AdverseReaction 2499 2520;2527 2534;2550 2560	acute exacerbation of cardiac compromise
T56	Severity 2491 2498	serious
T57	Factor 2473 2476	may
T58	AdverseReaction 2499 2520;2538 2560	acute exacerbation of respiratory compromise
T59	AdverseReaction 2568 2582	fluid overload
E1	AdverseReaction:T1 Hypothetical:E2
E2	Factor:T2
E3	AdverseReaction:T3 Hypothetical:E2
E4	AdverseReaction:T4 Hypothetical:E2
E5	AdverseReaction:T5 Hypothetical:E6
E6	Factor:T6
E7	AdverseReaction:T7 Hypothetical:E11
E8	AdverseReaction:T8 Hypothetical:E11
E9	AdverseReaction:T9 Hypothetical:E11
E10	AdverseReaction:T10 Hypothetical:E12
E11	Factor:T11
E12	Factor:T12
E13	AdverseReaction:T13 Effect:E14
E14	Severity:T14
E15	AdverseReaction:T15 Effect:E16
E16	Severity:T16
E17	AdverseReaction:T17
E18	AdverseReaction:T18
E19	AdverseReaction:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E24	AdverseReaction:T24
E25	AdverseReaction:T25
E26	AdverseReaction:T26
E27	AdverseReaction:T27
E28	AdverseReaction:T28
E29	AdverseReaction:T29
E30	AdverseReaction:T30
E31	AdverseReaction:T31
E32	AdverseReaction:T32
E33	AdverseReaction:T33
E34	AdverseReaction:T34
E35	AdverseReaction:T35
E36	AdverseReaction:T36
E37	AdverseReaction:T37 Hypothetical:E38 Effect:E39
E38	Factor:T38
E39	Severity:T39
E40	AdverseReaction:T40 Hypothetical:E38 Effect:E39
E41	AdverseReaction:T41 Hypothetical:E45
E42	AdverseReaction:T42 Hypothetical:E45
E43	AdverseReaction:T43 Hypothetical:E45
E44	AdverseReaction:T44 Hypothetical:E46
E45	Factor:T45
E46	Factor:T46
E47	AdverseReaction:T47 Effect:E48
E48	Severity:T48
E49	AdverseReaction:T49 Effect:E50
E50	Severity:T50
E51	AdverseReaction:T51
E52	AdverseReaction:T52
E53	AdverseReaction:T53
E54	AdverseReaction:T54
E55	AdverseReaction:T55 Effect:E56 Hypothetical:E57
E56	Severity:T56
E57	Factor:T57
E58	AdverseReaction:T58 Effect:E56 Hypothetical:E57
E59	AdverseReaction:T59
A1	CUI E1 C0002792
A2	UMLS-Preferred-Name E1 anaphylaxis
A3	MEDDRA-PT E1 Anaphylactic reaction
A4	MEDDRA-PT-ID E1 10002198
A5	LLT E1 Anaphylaxis
A6	LLT-ID E1 10002218
A7	CUI E3 C0020517
A8	UMLS-Preferred-Name E3 Hypersensitivity
A9	MEDDRA-PT E3 Hypersensitivity
A10	MEDDRA-PT-ID E3 10020751
A11	CUI E4 C0020517
A12	UMLS-Preferred-Name E4 Hypersensitivity
A13	MEDDRA-PT E4 Hypersensitivity
A14	MEDDRA-PT-ID E4 10020751
A15	CUI E5 C1444565
A16	UMLS-Preferred-Name E5 Cardiorespiratory failure
A17	MEDDRA-PT E5 Cardiopulmonary failure
A18	MEDDRA-PT-ID E5 10051093
A19	LLT E5 Cardio-respiratory failure
A20	LLT-ID E5 10049125
A21	CUI E7 C0002792
A22	UMLS-Preferred-Name E7 anaphylaxis
A23	MEDDRA-PT E7 Anaphylactic reaction
A24	MEDDRA-PT-ID E7 10002198
A25	LLT E7 Anaphylaxis
A26	LLT-ID E7 10002218
A27	CUI E8 C0020517
A28	UMLS-Preferred-Name E8 Hypersensitivity
A29	MEDDRA-PT E8 Hypersensitivity
A30	MEDDRA-PT-ID E8 10020751
A31	CUI E9 C0020517
A32	UMLS-Preferred-Name E9 Hypersensitivity
A33	MEDDRA-PT E9 Hypersensitivity
A34	MEDDRA-PT-ID E9 10020751
A35	CUI E10 C1444565
A36	UMLS-Preferred-Name E10 Cardiorespiratory failure
A37	MEDDRA-PT E10 Cardiopulmonary failure
A38	MEDDRA-PT-ID E10 10051093
A39	LLT E10 Cardio-respiratory failure
A40	LLT-ID E10 10049125
A41	CUI E13 C0002792
A42	UMLS-Preferred-Name E13 anaphylaxis
A43	MEDDRA-PT E13 Anaphylactic reaction
A44	MEDDRA-PT-ID E13 10002198
A45	CUI E15 C0020517
A46	UMLS-Preferred-Name E15 Hypersensitivity
A47	MEDDRA-PT E15 Hypersensitivity
A48	MEDDRA-PT-ID E15 10020751
A49	LLT E15 Hypersensitivity reaction
A50	LLT-ID E15 10020756
A51	CUI E17 C0476273
A52	UMLS-Preferred-Name E17 Respiratory distress
A53	MEDDRA-PT E17 Respiratory distress
A54	MEDDRA-PT-ID E17 10038687
A55	CUI E18 C0242184
A56	UMLS-Preferred-Name E18 Hypoxia
A57	MEDDRA-PT E18 Hypoxia
A58	MEDDRA-PT-ID E18 10021143
A59	CUI E19 C0003578
A60	UMLS-Preferred-Name E19 Apnea
A61	MEDDRA-PT E19 Apnoea
A62	MEDDRA-PT-ID E19 10002974
A63	LLT E19 Apnea
A64	LLT-ID E19 10002972
A65	CUI E20 C0013404
A66	UMLS-Preferred-Name E20 Dyspnea
A67	MEDDRA-PT E20 Dyspnoea
A68	MEDDRA-PT-ID E20 10013968
A69	LLT E20 Dyspnea
A70	LLT-ID E20 10013963
A71	CUI E21 C0428977
A72	UMLS-Preferred-Name E21 Bradycardia
A73	MEDDRA-PT E21 Bradycardia
A74	MEDDRA-PT-ID E21 10006093
A75	CUI E22 C0039231
A76	UMLS-Preferred-Name E22 Tachycardia
A77	MEDDRA-PT E22 Tachycardia
A78	MEDDRA-PT-ID E22 10043071
A79	CUI E23 C0006266
A80	UMLS-Preferred-Name E23 Bronchial Spasm
A81	MEDDRA-PT E23 Bronchospasm
A82	MEDDRA-PT-ID E23 10006482
A83	CUI E24 C0236071
A84	UMLS-Preferred-Name E24 Feeling of throat tightness
A85	MEDDRA-PT E24 Throat tightness
A86	MEDDRA-PT-ID E24 10043528
A87	CUI E25 C0020649
A88	UMLS-Preferred-Name E25 Hypotension
A89	MEDDRA-PT E25 Hypotension
A90	MEDDRA-PT-ID E25 10021097
A91	CUI E26 C0002994
A92	UMLS-Preferred-Name E26 Angioedema
A93	MEDDRA-PT E26 Angioedema
A94	MEDDRA-PT-ID E26 10002424
A95	CUI E27 C0236068
A96	UMLS-Preferred-Name E27 Tongue swelling
A97	MEDDRA-PT E27 Swollen tongue
A98	MEDDRA-PT-ID E27 10042727
A99	LLT E27 Tongue swelling non-specific
A100	LLT-ID E27 10043984
A101	CUI E28 C0240211
A102	UMLS-Preferred-Name E28 Lip swelling
A103	MEDDRA-PT E28 Lip swelling
A104	MEDDRA-PT-ID E28 10024570
A105	CUI E29 C0151205
A106	UMLS-Preferred-Name E29 Periorbital edema
A107	MEDDRA-PT E29 Periorbital oedema
A108	MEDDRA-PT-ID E29 10034545
A109	LLT E29 Periorbital edema
A110	LLT-ID E29 10054541
A111	CUI E30 C0542571
A112	UMLS-Preferred-Name E30 Facial edema
A113	MEDDRA-PT E30 Face oedema
A114	MEDDRA-PT-ID E30 10016029
A115	LLT E30 Face edema
A116	LLT-ID E30 10016025
A117	CUI E31 C0042109
A118	UMLS-Preferred-Name E31 Urticaria
A119	MEDDRA-PT E31 Urticaria
A120	MEDDRA-PT-ID E31 10046735
A121	CUI E32 C0020517
A122	UMLS-Preferred-Name E32 Hypersensitivity
A123	MEDDRA-PT E32 Hypersensitivity
A124	MEDDRA-PT-ID E32 10020751
A125	CUI E33 C0033687
A126	UMLS-Preferred-Name E33 Proteinuria
A127	MEDDRA-PT E33 Proteinuria
A128	MEDDRA-PT-ID E33 10037032
A129	CUI E34 C0027726
A130	UMLS-Preferred-Name E34 Nephrotic Syndrome
A131	MEDDRA-PT E34 Nephrotic syndrome
A132	MEDDRA-PT-ID E34 10029164
A133	CUI E35 C0151799
A134	UMLS-Preferred-Name E35 Skin necrosis
A135	MEDDRA-PT E35 Skin necrosis
A136	MEDDRA-PT-ID E35 10040893
A137	CUI E36 C0546817
A138	UMLS-Preferred-Name E36 Fluid overload
A139	MEDDRA-PT E36 Fluid overload
A140	MEDDRA-PT-ID E36 10016803
A141	CUI E37 C0035204
A142	UMLS-Preferred-Name E37 Respiration Disorders
A143	MEDDRA-PT E37 Respiratory disorder
A144	MEDDRA-PT-ID E37 10038683
A145	CUI E40 C0018799
A146	UMLS-Preferred-Name E40 Heart Diseases
A147	MEDDRA-PT E40 Cardiac disorder
A148	MEDDRA-PT-ID E40 10061024
A149	CUI E41 C0002792
A150	UMLS-Preferred-Name E41 anaphylaxis
A151	MEDDRA-PT E41 Anaphylactic reaction
A152	MEDDRA-PT-ID E41 10002198
A153	LLT E41 Anaphylaxis
A154	LLT-ID E41 10002218
A155	CUI E42 C0020517
A156	UMLS-Preferred-Name E42 Hypersensitivity
A157	MEDDRA-PT E42 Hypersensitivity
A158	MEDDRA-PT-ID E42 10020751
A159	CUI E43 C0020517
A160	UMLS-Preferred-Name E43 Hypersensitivity
A161	MEDDRA-PT E43 Hypersensitivity
A162	MEDDRA-PT-ID E43 10020751
A163	CUI E44 C1444565
A164	UMLS-Preferred-Name E44 Cardiorespiratory failure
A165	MEDDRA-PT E44 Cardiopulmonary failure
A166	MEDDRA-PT-ID E44 10051093
A167	LLT E44 Cardio-respiratory failure
A168	LLT-ID E44 10049125
A169	CUI E47 C0002792
A170	UMLS-Preferred-Name E47 anaphylaxis
A171	MEDDRA-PT E47 Anaphylactic reaction
A172	MEDDRA-PT-ID E47 10002198
A173	CUI E49 C0020517
A174	UMLS-Preferred-Name E49 Hypersensitivity
A175	MEDDRA-PT E49 Hypersensitivity
A176	MEDDRA-PT-ID E49 10020751
A177	LLT E49 Hypersensitivity reaction
A178	LLT-ID E49 10020756
A179	CUI E51 C0020517
A180	UMLS-Preferred-Name E51 Hypersensitivity
A181	MEDDRA-PT E51 Hypersensitivity
A182	MEDDRA-PT-ID E51 10020751
A183	CUI E52 C0033687
A184	UMLS-Preferred-Name E52 Proteinuria
A185	MEDDRA-PT E52 Proteinuria
A186	MEDDRA-PT-ID E52 10037032
A187	CUI E53 C0027726
A188	UMLS-Preferred-Name E53 Nephrotic Syndrome
A189	MEDDRA-PT E53 Nephrotic syndrome
A190	MEDDRA-PT-ID E53 10029164
A191	CUI E54 C0151799
A192	UMLS-Preferred-Name E54 Skin necrosis
A193	MEDDRA-PT E54 Skin necrosis
A194	MEDDRA-PT-ID E54 10040893
A195	CUI E55 C0018799
A196	UMLS-Preferred-Name E55 Heart Diseases
A197	MEDDRA-PT E55 Cardiac disorder
A198	MEDDRA-PT-ID E55 10061024
A199	CUI E58 C0035204
A200	UMLS-Preferred-Name E58 Respiration Disorders
A201	MEDDRA-PT E58 Respiratory disorder
A202	MEDDRA-PT-ID E58 10038683
A203	CUI E59 C0546817
A204	UMLS-Preferred-Name E59 Fluid overload
A205	MEDDRA-PT E59 Fluid overload
A206	MEDDRA-PT-ID E59 10016803
